πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

359 results for β€œvaccine” Clear

  1. VX15/2503

    VACCINEX, INC.

    Multiple Sclerosis

    phase 1 small molecule completed

    1 trial

  2. VX15/2503

    VACCINEX, INC.

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  3. VX15/2503

    VACCINEX, INC.

    Squamous Cell Carcinoma of the Head and Neck

    phase 1 mab active

    1 trial

  4. Vaccine/device combination for prevention of HFRS

    United Therapeutics Europe Ltd

    Hemorrhagic Fever With Renal Syndrome

    phase 1 mab completed

    1 trial

  5. Venezuelan Equine Encephalitis DNA Vaccine

    United Therapeutics Europe Ltd

    Vaccine Reaction

    phase 1 small molecule active

    1 trial

  6. WT1-loaded CBDC Vaccine

    AXIM BIOTECHNOLOGIES, INC.

    AML: Acute Myeloid Leukemia/ cancer of blood and bone marrow

    phase 1 small molecule active

    1 trial

  7. an inactivated whole virion H5N1 vaccine, adjuvanted

    Sinovac Research and Development Co.,

    Influenza

    phase 1 mab completed

    1 trial

  8. high-dose Group ACYW135X Meningococcal Conjugate Vaccine

    Sinovac Research and Development Co.,

    Meningococcal Meningitis

    phase 1 mab active

    1 trial

  9. pandemic influenza vaccine (H5N1 strain NIBRG-14)

    Sinovac Research and Development Co.,

    Pandemic Influenza Vaccine

    phase 1 mab completed

    1 trial

  10. Ξ±-lactalbumin vaccine

    Anixa Biosciences Inc

    Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer

    phase 1 mab active

    1 trial

  11. 20 Β΅g recombinant hepatitis B vaccine at months 0, 1, and 6

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab active

    3 trials

  12. 2012-2013 trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  13. 23-valent pneumococcal polysaccharide vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab completed

    1 trial

  14. 5000 volunteers (6-35 months)-EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  15. 60 Β΅g dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab completed

    1 trial

  16. 60 Β΅g dose hepatitis B vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccination

    approved mab completed

    1 trial

  17. Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

    Pfizer Australia Pty Ltd

    RSV-infection

    approved small molecule active

    1 trial

  18. Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar sus

    Pfizer Australia Pty Ltd

    VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA

    approved small molecule active

    1 trial

  19. Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    approved small molecule active

    1 trial

  20. BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    Hipra Human Health S.L.

    COVID-19

    approved small molecule active

    1 trial

  21. BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted), Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection COVID 19 mRNA Vaccine, Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Comirnaty JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Nuvaxovid dispersion for injection COVI

    The George Institute

    COVID-19 infection

    approved small molecule active

    1 trial

  22. BLB-750 Vaccine (Qinghai RG strain)

    Takeda

    Pandemic Influenza Prevention

    approved mab completed

    1 trial

  23. CAPVAXIVE solution for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (21-valent), Prevenar 20 suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

    Disc Medicine

    Asplenia

    approved small molecule active

    1 trial

  24. COVID-19 Vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources